Codice QR

Comparison of clinical outcomes with orodispersible versus standard oral olanzapine tablets in nonadherent patients with schizophrenia or bipolar disorder

Diego Novick,1 William Montgomery,2 Tamas Treuer,3 Ai Koyanagi,4 Jaume Aguado,4 Susanne Kraemer,5 Josep Maria Haro4 1Global Patient Outcomes and Real World Evidence (GPORWE), Eli Lilly and Company, Windlesham, Surrey, UK; 2Global Patient Outcomes and Real World Evidence (GPORWE), Eli Lilly Aus...

Descrizione completa

Salvato in:
Autori principali: Novick D, Montgomery W, Treuer T, Koyanagi A, Aguado J, Kraemer S, Haro JM
Natura: Artigo
Lingua:Inglês
Pubblicazione: Dove Medical Press 2017-06-01
Serie:Patient Preference and Adherence
Soggetti:
olanzapine
schizophrenia
bipolar disorder
orodispersible formulation
relapse
hospitalization
Accesso online:https://www.dovepress.com/comparison-of-clinical-outcomes-with-orodispersible-versus-standard-or-peer-reviewed-article-PPA
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi